The DOI matches its Crossref record; 112 of the 112 references it cites were found in a registry or an index.
Epidemiology and natural history of HCV infection
Open accessAbstract
Worldwide, an estimated 130–170 million people have HCV infection. HCV prevalence is highest in Egypt at >10% of the general population and China has the most people with HCV (29.8 million). Differences in past HCV incidence and current HCV prevalence, together with the generally protracted nature of HCV disease progression, has led to considerable diversity in the burden of advanced liver disease in different countries. Countries with a high incidence of HCV or peak incidence in the recent past will have further escalations in HCV-related cirrhosis and hepatocellular carcinoma (HCC) over the next two decades. Acute HCV infection is difficult to detect because of the generally asymptomatic nature of the disease and the marginalization of at-risk populations. Around 25% of patients with acute HCV infection undergo spontaneous clearance, with increased rates among those with favourable IL28B genotypes, acute symptoms and in women. The remaining 75% of patients progress to chronic HCV infection and are subsequently at risk of progression to hepatic fibrosis, cirrhosis and HCC. Chronic hepatitis C generally progresses slowly in the initial two decades, but can be accelerated during this time as a result of advancing age and co-factors such as heavy alcohol intake and HIV co-infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
El–Serag, H. B., & Rudolph, K. L. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.061 · Cited by 5,415
Natural history of liver fibrosis progression in patients with chronic hepatitis C
Poynard, T., Bedossa, P., & Opolon, P. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07642-8 · Cited by 3,011
The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994
Alter, M. J., Kruszon-Moran, D., Nainan, O. V., McQuillan, G. M., Gao, F., Moyer, L. A., Kaslow, R. A., & Margolis, H. S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908193410802 · Cited by 2,992
Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
Fattovich, G., Stroffolini, T., Zagni, I., & Donato, F. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.014 · Cited by 2,591
Perz, J. F., Armstrong, G. L., Farrington, L. A., Hutin, Y. J. F., & Bell, B. P. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.05.013 · Cited by 2,572
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
Thomas, D. L., Thio, C. L., Martin, M. P., Qi, Y., Ge, D., O’hUigin, C., Kidd, J., Kidd, K., Khakoo, S. I., Alexander, G., et al. (2009) · Nature · doi:10.1038/nature08463 · Cited by 2,150
The Prevalence of Hepatitis C Virus Infection in the United States, 1999 through 2002
Armstrong, G. L., Wasley, A., Simard, E. P., McQuillan, G. M., Kuhnert, W. L., & Alter, M. J. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-10-200605160-00004 · Cited by 1,955
Natural history of chronic hepatitis C
Seeff, L. B. (2002) · Hepatology · doi:10.1053/jhep.2002.36806 · Cited by 1,424
The global burden of hepatitis C
Lavanchy, D. (2009) · Liver International · doi:10.1111/j.1478-3231.2008.01934.x · Cited by 1,368
Epidemiology of hepatitis C virus infection
Alter, M. J. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i17.2436 · Cited by 1,339
Evolving epidemiology of hepatitis C virus
Lavanchy, D. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03432.x · Cited by 1,318
[Gastric adenocarcinoma and kidney transplantation].
Barrio, J., García-Bengoechea, M., Emparanza, J. I., & Arenas, J. I. (1998) · PubMed · Cited by 1,132
The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt
Frank, C., Mohamed, M. K., Strickland, G. T., Lavanchy, D., Arthur, R. R., Magder, L. S., Khoby, T. E., Abdel-Wahab, Y., Ohn, E. S. A., Anwar, W., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(99)06527-7 · Cited by 1,131
Outcomes of Treatment for Hepatitis C Virus Infection by Primary Care Providers
Arora, S., Thornton, K., Murata, G., Deming, P., Kalishman, S., Dion, D., Parish, B., Burke, T., Pak, W., Dunkelberg, J., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009370 · Cited by 1,076
Epidemiology of Hepatitis C: Geographic Differences and Temporal Trends
Wasley, A., & Alter, M. J. (2000) · Seminars in Liver Disease · doi:10.1055/s-2000-9506 · Cited by 979
Graham, C. S., Baden, L. R., Yu, E., Mrus, J. M., Carnie, J., Heeren, T., & Koziel, M. J. (2001) · Clinical Infectious Diseases · doi:10.1086/321909 · Cited by 974
Davis, G. L., Alter, M. J., El–Serag, H., Poynard, T., & Jennings, L. W. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.09.067 · Cited by 878
Micallef, J. M., Kaldor, J. M., & Dore, G. J. (2006) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2005.00651.x · Cited by 871
Self-citationThein, H., Yi, Q., Dore, G. J., & Krahn, M. D. (2008) · Hepatology · doi:10.1002/hep.22375 · Cited by 829
Self-citationRates and risk factors of liver fibrosis progression in patients with chronic hepatitis c
Poynard, T., Ratziu, V., Charlotte, F., Goodman, Z., McHutchison, J., & Albrecht, J. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(00)00097-0 · Cited by 749
Takaki, A., Wiese, M., Maertens, G., Depla, E., Seifert, U., Liebetrau, A., Miller, J. L., Manns, M. P., & Rehermann, B. (2000) · Nature Medicine · doi:10.1038/75063 · Cited by 739
Insulin resistance is associated with chronic hepatitis C and virus infection fibrosis progression
Hui, J. M., Sud, A., Farrell, G. C., Bandara, P., Byth, K., Kench, J. G., McCaughan, G. W., & George, J. (2003) · Gastroenterology · doi:10.1053/j.gastro.2003.08.032 · Cited by 718
Fibrosis in Chronic Hepatitis C Correlates Significantly With Body Mass Index and Steatosis
Hourigan, L. F., Macdonald, G. A., Purdie, D., Whitehall, V. H., Shorthouse, C., Clouston, A., & Powell, E. E. (1999) · Hepatology · doi:10.1002/hep.510290401 · Cited by 674
Estimating progression to cirrhosis in chronic hepatitis C virus infection
Freeman, A. J., Dore, G. J., Law, M. G., Thorpe, M., Von Overbeck, J., Lloyd, A. R., Marinos, G., & Kaldor, J. M. (2001) · Hepatology · doi:10.1053/jhep.2001.27831 · Cited by 620
Self-citationLeandro, G., Mangia, A., Hui, J., Fabris, P., Rubbia–Brandt, L., Colloredo, G., Adinolfi, L. E., Asselah, T., Jonsson, J. R., Smedile, A., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.03.014 · Cited by 565
Marcello, T., Grakoui, A., Barba–Spaeth, G., Machlin, E. S., Kotenko, S. V., Macdonald, M. R., & Rice, C. M. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.09.052 · Cited by 561
Lee, M.-H., Yang, H.-I., Lu, S.-N., Jen, C.-L., You, S.-L., Wang, L.-Y., Wang, C.-H., Chen, W. J., Chen, C.-J., & for the R.E.V.E.A.L.-HCV Study Group (2012) · Journal of Infectious Diseases · doi:10.1093/infdis/jis385 · Cited by 554
A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt
Sievert, W., Altraif, I., Razavi, H. A., Abdo, A., Ahmed, E. A., AlOmair, A., Amarapurkar, D., Chen, C., Dou, X., El Khayat, H., et al. (2011) · Liver International · doi:10.1111/j.1478-3231.2011.02540.x · Cited by 534
Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence
Rehermann, B. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39133 · Cited by 531
Armstrong, G. L., Alter, M. J., McQuillan, G. M., & Margolis, H. S. (2000) · Hepatology · doi:10.1002/hep.510310332 · Cited by 523
McOmish, F., Yap, P. L., Dow, B. C., Follett, E. A., Seed, C., Keller, A. J., Cobain, T. J., Krusius, T., Kolho, E., & Naukkarinen, R. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.4.884-892.1994 · Cited by 509
Global Burden of Disease (GBD) for Hepatitis C
The Global Burden of Hepatitis C Working Group (2004) · The Journal of Clinical Pharmacology · doi:10.1177/0091270003258669 · Cited by 488
The changing epidemiology of hepatitis C virus infection in Europe
Esteban, J. I., Sauleda, S., & Quer, J. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2007.07.033 · Cited by 481
Masuzaki, R., Tateishi, R., Yoshida, H., Goto, E., Sato, T., Ohki, T., Imamura, J., Goto, T., Kanai, F., Kato, N., et al. (2009) · Hepatology · doi:10.1002/hep.22870 · Cited by 435
A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel
Cornberg, M., Razavi, H. A., Alberti, A., Bernasconi, E., Buti, M., Cooper, C., Dalgard, O., Dillion, J. F., Flisiak, R., Forns, X., et al. (2011) · Liver International · doi:10.1111/j.1478-3231.2011.02539.x · Cited by 411
Thein, H.-H., Yi, Q., Dore, G. J., & Krahn, M. D. (2008) · AIDS · doi:10.1097/qad.0b013e32830e6d51 · Cited by 409
Self-citationHepatitis C virus infection in USA: an estimate of true prevalence
Chak, E., Talal, A. H., Sherman, K. E., Schiff, E. R., & Saab, S. (2011) · Liver International · doi:10.1111/j.1478-3231.2011.02494.x · Cited by 396
Hepatitis B and hepatitis C in Pakistan: prevalence and risk factors
Ali, S. A., Donahue, R. M. J., Qureshi, H., & Vermund, S. H. (2009) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2008.06.019 · Cited by 361
Degenhardt, L., Randall, D., Hall, W., Law, M., Butler, T., & Burns, L. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.05.021 · Cited by 338
Giordano, T. P., Henderson, L., Landgren, O., Chiao, E. Y., Kramer, J. R., El-Serag, H., & Engels, E. A. (2007) · JAMA · doi:10.1001/jama.297.18.2010 · Cited by 332
Tillmann, H. L., Thompson, A. J., Patel, K., Wiese, M., Tenckhoff, H., Nischalke, H. D., Lokhnygina, Y., Kullig, U., Göbel, U., Capka, E., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.07.005 · Cited by 322
Hepatitis C genotype 4: What we know and what we don't yet know†
Kamal, S. M., & Nasser, I. A. (2008) · Hepatology · doi:10.1002/hep.22127 · Cited by 301
Daily Cannabis Smoking as a Risk Factor for Progression of Fibrosis in Chronic Hepatitis C *
Hézode, C., Roudot-Thoraval, F., Nguyen, S., Grenard, P., Julien, B., Zafrani, E.-S., Pawlostky, J.-M., Dhumeaux, D., Lotersztajn, S., & Mallat, A. (2005) · Hepatology · doi:10.1002/hep.20733 · Cited by 293
Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C
Bochud, P.-Y., Cai, T., Overbeck, K., Bochud, M., Dufour, J.-F., Müllhaupt, B., Borovicka, J., Heim, M., Moradpour, D., Cerny, A., et al. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.05.016 · Cited by 287
Page, K., Hahn, J. A., Evans, J., Shiboski, S., Lum, P., Delwart, E., Tobler, L., Andrews, W., Avanesyan, L., Cooper, S., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/605947 · Cited by 285
Hepatitis C--global prevalence (update).
(1999) · PubMed · Cited by 270
Surveillance and epidemiology of hepatitis B and C in Europe – a review
Rantala, M., & van de Laar, M. J. (2008) · Eurosurveillance · doi:10.2807/ese.13.21.18880-en · Cited by 245
XIA, G., LIU, C., CAO, H., BI, S., ZHAN, M., SU, C., NAN, J., & QI, X. (1996) · International Hepatology Communications · doi:10.1016/s0928-4346(96)82012-3 · Cited by 240
Mühlberger, N., Schwarzer, R., Lettmeier, B., Sroczynski, G., Zeuzem, S., & Siebert, U. (2009) · BMC Public Health · doi:10.1186/1471-2458-9-34 · Cited by 239
Prospective Evaluation of Community‐Acquired Acute‐Phase Hepatitis C Virus Infection
Cox, A. L., Netski, D. M., Mosbruger, T., Sherman, S. G., Strathdee, S., Ompad, D., Vlahov, D., Chien, D., Shyamala, V., Ray, S. C., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/428578 · Cited by 231
Meffre, C., Le Strat, Y., Delarocque‐Astagneau, E., Dubois, F., Antona, D., Lemasson, J., Warszawski, J., Steinmetz, J., Coste, D., Meyer, J., et al. (2010) · Journal of Medical Virology · doi:10.1002/jmv.21734 · Cited by 231
Epidemiology of hepatitis C in the United States
Williams, I. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00373-3 · Cited by 230
Yoshizawa, H. (2002) · Oncology · doi:10.1159/000048270 · Cited by 229
Public health impact of antiviral therapy for hepatitis C in the United States†
Volk, M. L., Tocco, R., Saini, S., & Lok, A. S. F. (2009) · Hepatology · doi:10.1002/hep.23220 · Cited by 224
Rhinoviruses replicate effectively at lower airway temperatures
Papadopoulos, N. G., Sanderson, G., Hunter, J., & Johnston, S. L. (1999) · Journal of Medical Virology · doi:10.1002/(sici)1096-9071(199905)58:1<44::aid-jmv6>3.0.co;2-u · Cited by 219
Dynamics of viremia in early hepatitis C virus infection
Glynn, S. A., Wright, D. J., Kleinman, S. H., Hirschkorn, D., Tu, Y., Heldebrant, C., Smith, R., Giachetti, C., Gallarda, J., & Busch, M. P. (2005) · Transfusion · doi:10.1111/j.1537-2995.2005.04390.x · Cited by 217
HCV burden of infection in Egypt: results from a nationwide survey
Guerra, J., Garenne, M., Mohamed, M. K., & Fontanet, A. (2012) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2011.01576.x · Cited by 213
Influence of Alcohol on the Progression of Hepatitis C Virus Infection: A Meta-analysis
Hutchinson, S. J., Bird, S. M., & Goldberg, D. J. (2005) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(05)00407-6 · Cited by 208
Cigarette Smoking and Hepatic Lesions in Patients With Chronic Hepatitis C
Pessione, F., Ramond, M.-J., Njapoum, C., Duchatelle, V., Degott, C., Erlinger, S., Rueff, B., Valla, D.-C., & Degos, F. (2001) · Hepatology · doi:10.1053/jhep.2001.25385 · Cited by 207
Evidence of intense ongoing endemic transmission of hepatitis C virus in Egypt
Miller, F. D., & Abu-Raddad, L. J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1008877107 · Cited by 203
Orland, J. R., Wright, T. L., & Cooper, S. (2001) · Hepatology · doi:10.1053/jhep.2001.22112 · Cited by 196
Ray, S. C., Wang, Y.-M., Laeyendecker, O., Ticehurst, J. R., Villano, S. A., & Thomas, D. L. (1999) · Journal of Virology · doi:10.1128/jvi.73.4.2938-2946.1999 · Cited by 195
The global health burden of hepatitis C virus infection
Negro, F., & Alberti, A. (2011) · Liver International · doi:10.1111/j.1478-3231.2011.02537.x · Cited by 181
Incidence and Transmission Patterns of Acute Hepatitis C in the United States, 1982-2006
Williams, I. T., Bell, B. P., Kuhnert, W., & Alter, M. J. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.511 · Cited by 175
Grebely, J., Petoumenos, K., Hellard, M., Matthews, G. V., Suppiah, V., Applegate, T., Yeung, B., Marks, P., Rawlinson, W., Lloyd, A. R., et al. (2010) · Hepatology · doi:10.1002/hep.23850 · Cited by 171
Self-citationHepatitis C infection in African Americans: its natural history and histological progression
Wiley, T. (2002) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(01)04117-x · Cited by 169
Gaeta, G. B., Stornaiuolo, G., Precone, D. F., Lobello, S., Chiaramonte, M., Stroffolini, T., Colucci, G., & Rizzetto, M. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00470-7 · Cited by 167
Different seroprevalence and molecular epidemiology patterns of hepatitis C virus infection in Italy
Ansaldi, F., Bruzzone, B., Salmaso, S., Rota, M. C., Durando, P., Gasparini, R., & Icardi, G. (2005) · Journal of Medical Virology · doi:10.1002/jmv.20376 · Cited by 167
ANWAR, W., KHALED, H., AMRA, H., ELNEZAMI, H., & LOFFREDO, C. (2008) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2008.01.005 · Cited by 161
What Is Killing People with Hepatitis C Virus Infection?
Grebely, J., & Dore, G. J. (2011) · Seminars in Liver Disease · doi:10.1055/s-0031-1297922 · Cited by 161
Self-citationFibrogenic impact of high serum glucose in chro nic hepatitis C
Ratziu, V., Munteanu, M., Charlotte, F., Bonyhay, L., & Poynard, T. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00456-2 · Cited by 153
Rate and predictors of treatment prescription for hepatitis C
Butt, A. A., Justice, A. C., Skanderson, M., Rigsby, M. O., Good, C. B., & Kwoh, C. K. (2006) · Gut · doi:10.1136/gut.2006.099150 · Cited by 151
Age at infection affects the long-term outcome of transfusion-associated chronic hepatitis C
Minola, E., Prati, D., Suter, F., Maggiolo, F., Caprioli, F., Sonzogni, A., Fraquelli, M., Paggi, S., & Conte, D. (2002) · Blood · doi:10.1182/blood-2001-12-0192 · Cited by 143
Modelling the hepatitis C virus epidemic in Australia
Razali, K., Thein, H., Bell, J. C., Cooper‐Stanbury, M., Dolan, K. A., Dore, G. J., George, J., Kaldor, J. M., Karvelas, M., Li, J., et al. (2007) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2007.05.026 · Cited by 139
Self-citationIntrafamilial Transmission of Hepatitis C in Egypt *
Mohamed, M. K., Abdel‐Hamid, M., Mikhail, N. N. H., Abdel-Aziz, F., Medhat, A., Magder, L. S., Fix, A. D., & Strickland, T. G. (2005) · Hepatology · doi:10.1002/hep.20811 · Cited by 129
Declining Incidence of Hepatocellular Carcinoma in Osaka, Japan, from 1990 to 2003
Tanaka, H., Imai, Y., Hiramatsu, N., Ito, Y., Imanaka, K., Oshita, M., Hijioka, T., Katayama, K., Yabuuchi, I., Yoshihara, H., et al. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-11-200806030-00004 · Cited by 127
Impact of smoking on histological liver lesions in chronic hepatitis C
Hézode, C., Lonjon, I., Roudot‐Thoraval, F., Mavier, J.-P., Pawlotsky, J., Zafrani, E. S., & Dhumeaux, D. (2002) · Gut · doi:10.1136/gut.52.1.126 · Cited by 122
Grebely, J., Knight, E., Genoway, K. A., Viljoen, M., Khara, M., Elliott, D., Gallagher, L., Storms, M. M., Raffa, J. D., DeVlaming, S., et al. (2010) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e32832a8c4c · Cited by 121
Self-citationInduction and Evasion of Innate Antiviral Responses by Hepatitis C Virus
Lemon, S. M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.r109.099556 · Cited by 106
Page, K. A., Pappalardo, B. L., Tobler, L. H., Phelps, B. H., Edlin, B. R., Moss, A. R., Wright, T. L., Wright, D. J., OʼBrien, T. R., Caglioti, S., et al. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.01229-07 · Cited by 104
Improving the Diagnosis of Acute Hepatitis C Virus Infection with Expanded Viral Load Criteria
McGovern, B., Birch, C. E., Bowen, M. J., Reyor, L. L., Nagami, E. H., Chung, R. T., & Kim, A. Y. (2009) · Clinical Infectious Diseases · doi:10.1086/605561 · Cited by 99
Integrating HCV services for drug users: A model to improve engagement and outcomes
Sylvestre, D. L., & Zweben, J. E. (2007) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2007.01.010 · Cited by 97
Katsoulidou, A., Sypsa, V., Tassopoulos, N. C., Boletis, J., Karafoulidou, A., Ketikoglou, I., Tsantoulas, D., Vafiadi, I., Hatzis, G. S., Skoutelis, A. T., et al. (2005) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2005.00649.x · Cited by 93
Hepatitis C prevalence in England remains low and varies by ethnicity: an updated evidence synthesis
Harris, R., Ramsay, M. E., Hope, V. D., Brant, L. J., Hickman, M., Foster, G. R., & Angelis, D. D. (2011) · European Journal of Public Health · doi:10.1093/eurpub/ckr083 · Cited by 88
Expected increase in hepatitis C-related mortality in Egypt due to pre-2000 infections
Deuffic‐Burban, S., Mostafa, M., Larouzé, B., Carrat, F., & Valleron, A. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.08.008 · Cited by 87
Market uptake of new antiviral drugs for the treatment of hepatitis C
Lettmeier, B., Mühlberger, N., Schwarzer, R., Sroczynski, G., Wright, D. R., Zeuzem, S., & Siebert, U. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.04.021 · Cited by 86
Grebely, J., Raffa, J. D., Meagher, C., Duncan, F., Genoway, K. A., Khara, M., McLean, M., Mead, A., Viljoen, M., DeVlaming, S., et al. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.05032.x · Cited by 83
Self-citationLiu, L., Fisher, B. E., Thomas, D. L., Cox, A. L., & Ray, S. C. (2012) · Hepatology · doi:10.1002/hep.25575 · Cited by 79
Hepatitis C in the General Adult Population of Oslo: Prevalence and Clinical Spectrum
Dalgård, O., Jeansson, S. L., Skaug, K., Raknerud, N., & Bell, H. (2003) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520310004542 · Cited by 78
Global Burden of Disease (GBD) for Hepatitis C The Global Burden of Hepatitis C Working Group
Hutin, Y. J., Kitler, M. E., Dore, G. J., Armstrong, G. L., Dusheiko, G. M., Grob, P. J., Kew, M. C., Marcellin, P., Seeff, L. B., Beutels, P., et al. (2004) · Cited by 78
Self-citationHepatitis C virus infection in cameroon: A cohort‐effect
Nerrienet, E., Pouillot, R., Lachenal, G., Njouom, R., Mfoupouendoun, J., Bilong, C., Mauclère, P., Pasquier, C., & Ayouba, A. (2005) · Journal of Medical Virology · doi:10.1002/jmv.20343 · Cited by 75
HCV iatrogenic and intrafamilial transmission in Greater Cairo, Egypt
Jimenez, A. P., Eldin, N. S., Rimlinger, F., El-Daly, M. M., El-Hariri, H. M., El‐Hoseiny, M., Mohsen, A., Mostafa, A., Delarocque‐Astagneau, E., Abdel‐Hamid, M., et al. (2010) · Gut · doi:10.1136/gut.2009.194266 · Cited by 75
Cohort Profile: The Swiss Hepatitis C Cohort Study (SCCS)
Prasad, L., Spicher, V. M., Zwahlen, M., et al. (2007) · International Journal of Epidemiology · doi:10.1093/ije/dym096 · Cited by 71
Plasma interferon-gamma-inducible protein-10 (IP-10) levels during acute hepatitis C virus infection
Grebely, J., Feld, J. J., Applegate, T. L., Matthews, G. V., Hellard, M. E., Sherker, A., Petoumenos, K., Zang, G., Shaw, I., Yeung, B., et al. (2013) · Hepatology · doi:10.1002/hep.26263 · Cited by 70
Self-citationTrends in mortality after diagnosis of hepatitis B or C infection: 1992–2006
Walter, S. R., Thein, H., Amin, J., Gidding, H. F., Ward, K., Law, M. G., George, J., & Dore, G. J. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.08.035 · Cited by 67
Self-citationCase definitions for acute hepatitis C virus infection: A systematic review
Hajarizadeh, B., Grebely, J., & Dore, G. J. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.07.007 · Cited by 66
Self-citationHamada, H., Yatsuhashi, H., Yano, K., Daikoku, M., Arisawa, K., INOUE, O., Koga, M., Nakata, K., Eguchi, K., & Yano, M. (2002) · Cancer · doi:10.1002/cncr.10662 · Cited by 65
Plancoulaine, S., Mohamed, M. K., Arafa, N., Bakr, I., Rekacewicz, C., Trégouët, D., Obach, D., El-Daly, M. M., Thiers, V., Féray, C., et al. (2008) · Gut · doi:10.1136/gut.2007.140681 · Cited by 64
Hepatitis C virus infection in Eastern Europe
Naoumov, N. V. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80380-8 · Cited by 62
Grebely, J., Raffa, J., Lai, C., Kerr, T., Fischer, B., Krajden, M., Dore, G., & Tyndall, M. (2011) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2010.01279.x · Cited by 60
Self-citationDoes the clinical outcome of hepatitis C infection vary with the infecting hepatitis C virus type?
Harris, H., Eldridge, K. P., Harbour, S., Alexander, G., Teo, C., Ramsay, M. E., & The HCV National Register Steering Group (2006) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2006.00795.x · Cited by 56
Tanaka, Y., Hanada, K., Orito, E., Akahane, Y., Chayama, K., Yoshizawa, H., Sata, M., Ohta, N., Miyakawa, Y., Gojobori, T., et al. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.09.023 · Cited by 51
Injection Drug Use Is a Risk Factor for HCV Infection in Urban Egypt
Jimenez, A. P., Mohamed, M. K., Eldin, N. S., Seif, H. A., Aidi, S. E., Sultan, Y., Elsaid, N., Rekacewicz, C., El‐Hoseiny, M., El-Daly, M. M., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007193 · Cited by 49
An Incident Case–Control Study of Modes of Hepatitis C Virus Transmission in France
Delarocque‐Astagneau, E., Pillonel, J., de Valk, H., Perra, A., Laperche, S., & Desenclos, J. (2007) · Annals of Epidemiology · doi:10.1016/j.annepidem.2007.05.007 · Cited by 44
Simulation of hepatitis C based on a mandatory reporting system
Sagmeister, M., Renner, E. L., Müllhaupt, B., & Wong, J. B. (2002) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200201000-00006 · Cited by 44
Risk factors for hepatitis C virus infection among blood donors in northern Thailand
Thaikruea, L., Thongsawat, S., Maneekarn, N., Netski, D. M., Thomas, D. L., & Nelson, K. E. (2004) · Transfusion · doi:10.1111/j.1537-2995.2004.04073.x · Cited by 44
Larrey, D. G., Salse, A., Ribard, D., Boutet, O., Hyrailles, V., Niang, B., Pageaux, G., Vaucher, E., Arpurt, J. P., Boulay, G., et al. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.05.022 · Cited by 41
Liver cancer and hepatitis B and C in New South Wales, 1990–2002: a linkage study
Amin, J., O’Connell, D. L., Bartlett, M., Tracey, E. A., Kaldor, J. M., Law, M. G., & Dore, G. J. (2007) · Australian and New Zealand Journal of Public Health · doi:10.1111/j.1753-6405.2007.00121.x · Cited by 39
Self-citationBonner, J. E., Barritt, A. S., Fried, M. W., & Evon, D. M. (2012) · Digestive Diseases and Sciences · doi:10.1007/s10620-012-2141-4 · Cited by 32
Hepatitis C Seroprevalence and Associated Risk Factors, Anyang, China
Liu, F., Chen, K., He, Z., Ning, T., Pan, Y., Cai, H., & Yang, K. (2009) · Emerging infectious diseases · doi:10.3201/eid1511.0900263 · Cited by 25
Modelling the past, current and future HCV burden in France: detailed analysis and perspectives
Deuffic‐Burban, S., Mathurin, P., & Valleron, A. (2008) · Statistical Methods in Medical Research · doi:10.1177/0962280208094697 · Cited by 18
Cited by
A global view of hepatocellular carcinoma: trends, risk, prevention and management
Yang, J. D., Hainaut, P., Gores, G. J., Amadou, A., Plymoth, A., & Roberts, L. R. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0186-y · Cited by 4,228
Wong, R. J., Aguilar, M., Cheung, R., Perumpail, R. B., Harrison, S. A., Younossi, Z. M., & Ahmed, A. (2015) · Gastroenterology · doi:10.1053/j.gastro.2014.11.039 · Cited by 1,819
Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection
Feld, J. J., Jacobson, I. M., Hézode, C., Asselah, T., Ruane, P. J., Gruener, N., Abergel, A., Mangia, A., Lai, C.-L., Chan, H. L. Y., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1512610 · Cited by 1,106
ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis
Poordad, F., Hezode, C., Trinh, R., Kowdley, K. V., Zeuzem, S., Agarwal, K., Shiffman, M. L., Wedemeyer, H., Berg, T., Yoshida, E. M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402869 · Cited by 874
Peptide-Based Vaccines: Current Progress and Future Challenges
Malonis, R. J., Lai, J. R., & Vergnolle, O. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.9b00472 · Cited by 602
Metadata
- Authors
- Hajarizadeh, B., Grebely, J., & Dore, G. J.
- Venue
- Nature Reviews Gastroenterology & Hepatology
- Published
- 2013-07-02
- Volume
- 10
- Issue
- 9
- Pages
- 553-562
- ISSN
- 1759-5045 (ISSN-L)
- 1759-5053
- OpenAlex
- W2086887894
- Cited by
- 994
- References
- 112
- FWCI
- 15.42
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.